Immunogenicity of influenza vaccination in patients with cancer receiving immune checkpoint inhibitors

Bhumsuk Keam; Chang Kyung Kang; Kang Il Jun; Song Mi Moon; Koung Jin Suh; Dae Won Lee; Chan Young Ock; Miso Kim; Yunhee Choi; Yoojoo Lim; Kyung Hun Lee; Se Hyun Kim; Tae Min Kim; Tae Yong Kim; Do Youn Oh; Dong Wan Kim; Seock Ah Im; Jong Seok Lee; Eu Suk Kim; Hong Bin Kim; Nam Joong Kim; Yu Jung Kim; Wan Beom Park; Myoung Don Oh

doi:10.1093/cid/ciz1092

Immunogenicity of influenza vaccination in patients with cancer receiving immune checkpoint inhibitors

Bhumsuk Keam, Chang Kyung Kang, Kang Il Jun, Song Mi Moon, Koung Jin Suh, Dae Won Lee, Chan Young Ock, Miso Kim, Yunhee Choi, Yoojoo Lim, Kyung Hun Lee, Se Hyun Kim, Tae Min Kim, Tae Yong Kim, Do Youn Oh, Dong Wan Kim, Seock Ah Im, Jong Seok Lee, Eu Suk Kim, Hong Bin KimNam Joong Kim, Yu Jung Kim, Wan Beom Park, Myoung Don Oh

Research output: Contribution to journal › Article › peer-review

34 Scopus citations

Abstract

Among prospectively enrolled adult patients with cancer receiving immune checkpoint inhibitors (ICIs; n = 46) or cytotoxic agents (n = 90), seroprotection and seroconversion rates after seasonal quadrivalent influenza vaccinations were higher with ICI than with cytotoxic chemotherapy. These results support annual influenza vaccinations for cancer patients receiving ICIs.

Original language	English
Pages (from-to)	422-425
Number of pages	4
Journal	Clinical Infectious Diseases
Volume	71
Issue number	2
DOIs	https://doi.org/10.1093/cid/ciz1092
State	Published - 1 Jul 2020

Bibliographical note

Publisher Copyright:
© The Author(s) 2019. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved.

Keywords

Immune checkpoint inhibitor
Immune-related adverse event
Immunogenicity
Influenza
Vaccination

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1093/cid/ciz1092

Cite this

Keam, B., Kang, C. K., Jun, K. I., Moon, S. M., Suh, K. J., Lee, D. W., Ock, C. Y., Kim, M., Choi, Y., Lim, Y., Lee, K. H., Kim, S. H., Kim, T. M., Kim, T. Y., Oh, D. Y., Kim, D. W., Im, S. A., Lee, J. S., Kim, E. S., ... Oh, M. D. (2020). Immunogenicity of influenza vaccination in patients with cancer receiving immune checkpoint inhibitors. Clinical Infectious Diseases, 71(2), 422-425. https://doi.org/10.1093/cid/ciz1092

@article{9b15dd011ec743069effe6174dbaf38b,

title = "Immunogenicity of influenza vaccination in patients with cancer receiving immune checkpoint inhibitors",

abstract = "Among prospectively enrolled adult patients with cancer receiving immune checkpoint inhibitors (ICIs; n = 46) or cytotoxic agents (n = 90), seroprotection and seroconversion rates after seasonal quadrivalent influenza vaccinations were higher with ICI than with cytotoxic chemotherapy. These results support annual influenza vaccinations for cancer patients receiving ICIs.",

keywords = "Immune checkpoint inhibitor, Immune-related adverse event, Immunogenicity, Influenza, Vaccination",

author = "Bhumsuk Keam and Kang, {Chang Kyung} and Jun, {Kang Il} and Moon, {Song Mi} and Suh, {Koung Jin} and Lee, {Dae Won} and Ock, {Chan Young} and Miso Kim and Yunhee Choi and Yoojoo Lim and Lee, {Kyung Hun} and Kim, {Se Hyun} and Kim, {Tae Min} and Kim, {Tae Yong} and Oh, {Do Youn} and Kim, {Dong Wan} and Im, {Seock Ah} and Lee, {Jong Seok} and Kim, {Eu Suk} and Kim, {Hong Bin} and Kim, {Nam Joong} and Kim, {Yu Jung} and Park, {Wan Beom} and Oh, {Myoung Don}",

year = "2020",

month = jul,

day = "1",

doi = "10.1093/cid/ciz1092",

language = "English",

volume = "71",

pages = "422--425",

journal = "Clinical Infectious Diseases",

issn = "1058-4838",

publisher = "Oxford University Press",

number = "2",

}

Keam, B , Kang, CK, Jun, KI, Moon, SM , Suh, KJ , Lee, DW, Ock, CY, Kim, M, Choi, Y, Lim, Y, Lee, KH , Kim, SH , Kim, TM , Kim, TY , Oh, DY , Kim, DW , Im, SA , Lee, JS , Kim, ES , Kim, HB , Kim, NJ , Kim, YJ , Park, WB & Oh, MD 2020, 'Immunogenicity of influenza vaccination in patients with cancer receiving immune checkpoint inhibitors', Clinical Infectious Diseases, vol. 71, no. 2, pp. 422-425. https://doi.org/10.1093/cid/ciz1092

TY - JOUR

T1 - Immunogenicity of influenza vaccination in patients with cancer receiving immune checkpoint inhibitors

AU - Keam, Bhumsuk

AU - Kang, Chang Kyung

AU - Jun, Kang Il

AU - Moon, Song Mi

AU - Suh, Koung Jin

AU - Lee, Dae Won

AU - Ock, Chan Young

AU - Kim, Miso

AU - Choi, Yunhee

AU - Lim, Yoojoo

AU - Lee, Kyung Hun

AU - Kim, Se Hyun

AU - Kim, Tae Min

AU - Kim, Tae Yong

AU - Oh, Do Youn

AU - Kim, Dong Wan

AU - Im, Seock Ah

AU - Lee, Jong Seok

AU - Kim, Eu Suk

AU - Kim, Hong Bin

AU - Kim, Nam Joong

AU - Kim, Yu Jung

AU - Park, Wan Beom

AU - Oh, Myoung Don

PY - 2020/7/1

Y1 - 2020/7/1

N2 - Among prospectively enrolled adult patients with cancer receiving immune checkpoint inhibitors (ICIs; n = 46) or cytotoxic agents (n = 90), seroprotection and seroconversion rates after seasonal quadrivalent influenza vaccinations were higher with ICI than with cytotoxic chemotherapy. These results support annual influenza vaccinations for cancer patients receiving ICIs.

AB - Among prospectively enrolled adult patients with cancer receiving immune checkpoint inhibitors (ICIs; n = 46) or cytotoxic agents (n = 90), seroprotection and seroconversion rates after seasonal quadrivalent influenza vaccinations were higher with ICI than with cytotoxic chemotherapy. These results support annual influenza vaccinations for cancer patients receiving ICIs.

KW - Immune checkpoint inhibitor

KW - Immune-related adverse event

KW - Immunogenicity

KW - Influenza

KW - Vaccination

UR - http://www.scopus.com/inward/record.url?scp=85088206185&partnerID=8YFLogxK

U2 - 10.1093/cid/ciz1092

DO - 10.1093/cid/ciz1092

M3 - Article

C2 - 31680143

AN - SCOPUS:85088206185

SN - 1058-4838

VL - 71

SP - 422

EP - 425

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

IS - 2

ER -

Immunogenicity of influenza vaccination in patients with cancer receiving immune checkpoint inhibitors

Abstract

Bibliographical note

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this